Hepatitis Panel

Millions of people walk around with chronic hepatitis B or hepatitis C and have no idea. These infections can sit in your liver for decades without causing pain, fatigue, or any obvious warning sign, while slowly scarring the tissue and raising your risk of liver failure and liver cancer.

A hepatitis panel is the simplest way to answer three questions at once: have you ever been exposed to hepatitis A, B, or C, are you currently infected, and are you protected by vaccination or past immunity. Knowing your status changes what you can do about it, often dramatically.

What This Panel Actually Checks

This panel includes five separate blood tests, each looking for a different protein produced either by the virus itself or by your immune system in response to it. Together they distinguish between current infection, past infection that has cleared, and immunity from a vaccine.

• Hepatitis A antibody: a protein your immune system makes after exposure to hepatitis A, whether from infection or vaccination. A positive result means you are protected for life.
• Hepatitis B surface antigen (HBsAg): a piece of the hepatitis B virus itself. If this is positive, you currently have hepatitis B in your bloodstream, either as a recent infection or a long-standing chronic one.
• Hepatitis B surface antibody (anti-HBs): an immune protein that signals protection against hepatitis B, usually from vaccination or fully cleared past infection.
• Hepatitis B core antibody (anti-HBc): an immune protein that only appears after a real hepatitis B infection. It does not appear from vaccination, so it tells you whether your immunity came from the vaccine or from actually being infected at some point.
• Hepatitis C antibody (anti-HCV): an immune protein that appears after exposure to hepatitis C. A positive result means you have been infected at some point and need a follow-up test to see whether the virus is still active.

Why Hepatitis B Matters

Hepatitis B is one of the most common chronic viral infections in the world. The CDC estimates that hundreds of thousands of people in the United States are living with chronic hepatitis B, and most do not know it. The infection can be passed at birth, through sexual contact, through shared needles, or through medical or dental procedures in places with imperfect sterilization.

Untreated chronic hepatitis B substantially raises the long-term risk of cirrhosis (severe liver scarring) and hepatocellular carcinoma, the most common type of liver cancer. The good news is that modern antiviral medications can suppress the virus and substantially lower these risks when the infection is caught early.

If you were born outside the United States, especially in parts of Asia, Africa, the Pacific Islands, or Eastern Europe, your background risk is meaningfully higher. The CDC now recommends that every adult be tested for hepatitis B at least once in their lifetime, regardless of risk factors.

Why Hepatitis C Matters

Hepatitis C is a leading viral cause of liver cancer and liver transplant in the United States. It typically causes no symptoms for years or even decades, which is exactly why it spreads silently and gets diagnosed late.

Here is the part most people miss: hepatitis C is now curable. Direct-acting antiviral pills taken for 8 to 12 weeks clear the virus in well over 95% of people, with minimal side effects. A single positive antibody test followed by a confirmatory viral RNA test can lead directly to a cure. The CDC recommends one-time testing for all adults aged 18 and older.

Why Hepatitis A Matters

Hepatitis A is different from B and C in two important ways. It does not cause chronic infection, and it spreads mainly through contaminated food or water rather than blood or sex. An acute infection can still cause weeks of misery and, rarely, severe liver failure, but it almost always clears on its own.

The hepatitis A test on this panel checks for antibodies that signal lifelong immunity, either from vaccination or from a prior infection you may not even remember. It is most useful for confirming whether you are protected before traveling to a region where hepatitis A is common, or if you work in food service, healthcare, or childcare.

How to Read Your Results

Each test on this panel reports as positive (or reactive) or negative (or non-reactive). The pattern across the five tests tells the full story, not any single result on its own.

These categories are based on standard CDC interpretation of hepatitis serology. Your lab may use slightly different cutoffs or report ranges. Compare results within the same lab over time for the most meaningful trend.

Tracking Your Trend

For most people who test negative across the board, this is a one-time test that confirms your status and your vaccination history. You do not need to repeat it every year unless something changes.

Retest if your exposure risk changes. New sexual partners, a tattoo or piercing in a non-sterile setting, a needlestick injury, IV drug use, travel to high-prevalence regions, or starting a job in healthcare or first response are all reasons to retest. If you have ever been told you had a positive hepatitis B or C result, follow-up testing should be done at least annually under the guidance of a clinician, since active infection requires ongoing monitoring of liver enzymes, viral load, and liver imaging.

If you got vaccinated for hepatitis B in childhood and want to confirm you are still protected, the surface antibody test on this panel will tell you. Some people lose detectable antibody levels over decades, and a booster may be appropriate.

When Results Can Be Misleading

A few things can muddy the picture on a hepatitis panel and are worth knowing about before you draw conclusions from a single result.

• Window period: if you were exposed very recently (within the past few weeks), antibodies may not have developed yet. A negative result soon after a known exposure is not definitive. Retest in 8 to 12 weeks.
• Isolated core antibody positive: sometimes hepatitis B core antibody is positive while both surface antigen and surface antibody are negative. This can mean a resolved past infection, a false positive, or rarely an occult infection. It needs follow-up testing rather than panic.
• Hepatitis C antibody positive does not equal active infection: roughly 1 in 4 people clear hepatitis C on their own and remain antibody-positive for life. A positive antibody test must be followed by an RNA test to know whether the virus is currently in your blood.
• Recent immunoglobulin or blood products: if you received IV immunoglobulin or a blood transfusion in the past few months, you may have temporarily acquired antibodies that do not reflect your own immunity.